MEDIPOST Co., Ltd.
MEDIPOST is a KOSDAQ-listed (078160) cell-therapy company based in Seongnam. Its cartilage-regeneration product CARTISTEM has been approved in South Korea since 2012.
| Headquarters | Seongnam, South Korea |
|---|---|
| Listing | KOSDAQ:078160 |
| Lead asset / stage | CARTISTEM Approved — South Korea |
| Latest event | MEDIPOST disclosed a change of representative director. |